title: A case report of iatrogenic cutaneous Kaposi sarcoma due to rituximab therapy for thrombotic thrombocytopenic purpura.
authors.affiliation: a Department of Dermatology , University of Illinois at Chicago , Illinois , USA.
authors.forename: Kimberly
authors.initials: K
authors.lastname: Jerdan
authors.affiliation: a Department of Dermatology , University of Illinois at Chicago , Illinois , USA.
authors.forename: Joshua
authors.initials: J
authors.lastname: Brownell
authors.affiliation: b Department of Pathology , University of Illinois at Chicago , Illinois , USA.
authors.forename: Manu
authors.initials: M
authors.lastname: Singh
authors.affiliation: b Department of Pathology , University of Illinois at Chicago , Illinois , USA.
authors.forename: Marylee
authors.initials: M
authors.lastname: Braniecki
authors.affiliation: a Department of Dermatology , University of Illinois at Chicago , Illinois , USA.
authors.forename: Lawrence
authors.initials: L
authors.lastname: Chan
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D017679:Cryotherapy; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy*; D000069283:Rituximab / Q000009:adverse effects*; D012514:Sarcoma, Kaposi / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D000069283:Rituximab